Medical advertising is ordinary marketing carried out under three rulebooks at once. Federal advertising law requires that health claims be truthful and substantiated. Patient privacy law restricts what you may do with information about who visited which page and who called about what. And state licensing boards regulate how practitioners may describe their credentials, their specialties and their results. An agency that is excellent at retail advertising and has never encountered any of that will produce work that performs well and creates exposure that lands on your licence, not theirs. This page sets out what the constraints actually are, where the cost comes from, and the questions that reveal whether a candidate has done this work before.
Claims have to be substantiated before they are published
The FTC's health products compliance guidance is explicit that health related claims in advertising need competent and reliable evidence behind them, and it applies to services as much as to products. In practice that rules out a lot of copy that agencies write reflexively: pain free, permanent, guaranteed results, comparisons to other providers, and implied outcomes conveyed through before and after imagery. Testimonials are usable but carry conditions, including disclosure of any material connection between the patient and the practice and honesty about whether the experience shown is typical. The practical control is a review step. Somebody clinical signs off ad copy, landing pages and imagery before publication, and the agency builds that step into its schedule rather than discovering it in week three. Ask candidates how they have handled clinical review in the past. The ones who have done it will describe a process. The ones who have not will describe a turnaround time.
Tracking is where good agencies quietly create liability
The uncomfortable part of medical advertising is that ordinary marketing tooling collects exactly the information privacy law is most careful about. Advertising pixels, session recording, chat widgets and call tracking can transmit which condition page a person read, which appointment they requested and which provider they searched for, and that combination attached to an identifier is not neutral data. The HIPAA rules at 45 CFR Part 164 govern how protected health information may be used and disclosed, and any arrangement where a vendor handles that information on a covered entity's behalf needs the appropriate agreements in place. What this means for a buyer is that the tracking plan is a compliance decision and not a technical detail. Ask each candidate what they would install, what data it sends where, what they will not install on condition specific pages, and whether they have signed the necessary agreements with clients before. Vagueness here is disqualifying.
What moves the cost
Three things. First, the review cycle: if clinical and legal review sits between draft and publication, throughput drops and the agency has to schedule around it, which raises the effective cost of every asset. Second, the category. Elective and cash pay procedures such as cosmetic work, dental implants and orthopaedics attract high click prices because case values are high, while insurance driven primary care volume behaves completely differently. Third, geography and provider count, since a multi location group needs location pages, listings management and separate conversion tracking per site rather than one campaign with a wide radius. Quotes are only comparable when all three are described identically, so write a one page scope and send the same document to every candidate rather than accepting each firm's own framing of the work.
How practices actually buy this
Most practices are buying two things that get sold as one: visibility in search for the conditions and procedures they want more of, and paid campaigns for the ones where the case value justifies the click. Those are different disciplines with different timelines, and bundling them into a single monthly number makes it impossible to tell which half is working. Ask for them to be priced and reported separately even if one firm delivers both. When comparing a medical practice SEO and advertising company against a general agency, the differences that matter are whether they have worked inside a clinical review process, whether they can describe a compliant tracking setup without prompting, and whether the practice keeps ownership of the accounts, the listings and the content at the end. Everything else is negotiable.
Questions people ask about medical advertising
Can we use patient testimonials in ads?
Often yes, with care. You need documented consent, honesty about whether the result shown is typical, and disclosure of any material connection such as payment or free treatment. Some state boards impose extra restrictions on testimonials for specific specialties, so check the board rules for every state you advertise in before building a campaign around them.
Is call tracking safe for a medical practice?
It can be, with the right vendor arrangement and configuration. The questions to ask are what is recorded, where it is stored, who can access it, whether recordings are transcribed and fed into other systems, and whether the vendor will sign the agreements your compliance officer requires. Treat call tracking as a data processing decision rather than a marketing tool choice.
How long does medical search visibility take?
Longer than most categories, because health topics are held to a higher evidentiary bar and thin unsourced pages do poorly. Expect meaningful movement over quarters rather than weeks, and expect the clinical review cycle to be the rate limiting step. Agencies that promise fast results in this category are usually planning to publish content nobody reviewed.
What should be in the contract with the agency?
Ownership of accounts, listings, content and tracking implementations. A named clinical reviewer and an agreed turnaround. A written tracking plan stating what is and is not installed on condition pages. The data agreements your compliance officer requires. And a clean exit clause covering what transfers to you and in what format when the engagement ends.